SQL injection vulnerabilities occur when an attacker can interfere with the queries that an application makes to its database. You can use Burp to test for these vulnerabilities: Professional Use Burp ...
Apple got a mixed victory in a patent infringement lawsuit against medical device maker Masimo. On Friday, a federal jury determined that Masimo had infringed on some Apple patents, and as part of ...
Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...
Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...
Oct 25 (Reuters) - French drug maker Sanofi (SASY.PA), opens new tab on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than ...
Agomab Therapeutics is benefiting from Sanofi’s push to become an immunology powerhouse.
Sanofi reported a 25% boost in sales for its vaccines division during the third quarter, helped by earlier-than-anticipated orders of its flu shots as well as rising revenue from Beyfortus, its RSV ...
Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3. Sanofi released its third-quarter earnings report on Friday, beating ...
Credit: Hananeko_Studio via Shutterstock. Agomab Therapeutics has secured $89m in Series D funding to support clinical trials of its fibrotic disease treatments, with some help from Sanofi.
(Bloomberg) -- After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its over ... The sale of French generic drugmaker Biogaran to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback